Evidence map›Paper›PMID 20689700›Full record

ArticleExperimental diabetes research2010

Glucose regulation of thrombospondin and its role in the modulation of smooth muscle cell proliferation.

Laura A Maile, Lee B Allen, Christopher F Hanzaker, Katherine A Gollahon, Paul Dunbar, David R Clemmons

Open access · hybridAbstract read
In one paragraph

Article in Experimental diabetes research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. CD47 signaling pathways controlling cellular differentiation and responses to stress.Critical reviews in biochemistry and molecular biology · 2015
    Review
  6. Article
  7. The CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cells.Liver international : official journal of the International Association for the Study of the Liver · 2013
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. An essential role for the association of CD47 to SHPS-1 in skeletal remodeling.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Laura A MaileDivision of Endocrinology, University of North Carolina, CB# 7170, 5030 Burnett Womack, Chapel Hill, NC 27599-7170, USA. laura_maile@med.unc.edu
Lee B Allen
Christopher F Hanzaker
Katherine A Gollahon
Paul Dunbar
David R Clemmons
University of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Smooth muscle cells (SMC) maintained in high glucose are more responsive to IGF-I than those in normal glucose. There is significantly more thrombospondin-1 (TSP-1) in extracellular matrix surrounding SMC grown in 25 mM glucose. In this study we investigated 1) the mechanism by which glucose regulates TSP-1 levels and 2) the mechanism by which TS-1 enhances IGF-I signaling. The addition of TSP-1 to primary SMC was sufficient to enhance IGF-I responsiveness in normal glucose. Reducing TSP-1 protein levels inhibited IGF-I signaling in SMC maintained in high glucose. We determined that TSP-1 protected IAP/CD47 from cleavage and thereby facilitated its association with SHP substrate-1 (SHPS-1). We have shown previously that the hyperglycemia induced protection of IAP from cleavage is an important component of the ability of hyperglycemia to enhance IGF-I signaling. Furthermore we determined that TSP-1 also enhanced phosphorylation of the beta3 subunit of the alphaVbeta3 integrin, another molecular event that we have shown are critical for SMC response to IGF-I in high glucose. Our studies also revealed that the difference in the amount of TSP-1 in the two different glucose conditions was due, at least in part, to a difference in the cellular uptake and degradation of TSP-1.

Indexed as

Cell ProliferationAnimalsCD47 AntigenGlucoseHyperglycemiaInsulin-Like Growth Factor IIntegrin alphaVbeta3MaleMyocytes, Smooth MusclePhosphorylationSwineThrombospondin 1CD47 AntigenGlucoseInsulin-Like Growth Factor IIntegrin alphaVbeta3Thrombospondin 1

Identifiers

PMID20689700
PMCPMC2905704
OpenAlexW2100202350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.